Fjarde AP Fonden Fourth Swedish National Pension Fund reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 42,469 shares of the company's stock after selling 3,300 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund's holdings in HCA Healthcare were worth $19,827,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of HCA. Prestige Wealth Management Group LLC raised its position in HCA Healthcare by 173.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,088 shares of the company's stock worth $508,000 after acquiring an additional 690 shares in the last quarter. Harvest Fund Management Co. Ltd raised its position in HCA Healthcare by 92.3% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 2,990 shares of the company's stock worth $1,395,000 after acquiring an additional 1,435 shares in the last quarter. Prudential PLC raised its position in HCA Healthcare by 2.9% in the fourth quarter. Prudential PLC now owns 7,037 shares of the company's stock worth $3,285,000 after acquiring an additional 200 shares in the last quarter. Deseret Mutual Benefit Administrators raised its position in HCA Healthcare by 5.3% in the fourth quarter. Deseret Mutual Benefit Administrators now owns 1,291 shares of the company's stock worth $603,000 after acquiring an additional 65 shares in the last quarter. Finally, Vise Technologies Inc. raised its position in HCA Healthcare by 17.0% in the fourth quarter. Vise Technologies Inc. now owns 12,998 shares of the company's stock worth $6,068,000 after acquiring an additional 1,892 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities research analysts have commented on the stock. Jefferies Financial Group reiterated a "buy" rating and issued a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Robert W. Baird dropped their price target on HCA Healthcare from $450.00 to $442.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 15th. Cantor Fitzgerald reissued an "overweight" rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Royal Bank Of Canada dropped their price target on HCA Healthcare from $593.00 to $534.00 and set an "outperform" rating on the stock in a research note on Monday, April 27th. Finally, Sanford C. Bernstein dropped their price target on HCA Healthcare from $503.00 to $413.00 and set a "market perform" rating on the stock in a research note on Thursday. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $506.14.
Check Out Our Latest Report on HCA Healthcare
More HCA Healthcare News
Here are the key news stories impacting HCA Healthcare this week:
HCA Healthcare Price Performance
NYSE:HCA opened at $372.29 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The stock's 50-day moving average is $439.51 and its two-hundred day moving average is $477.20. The stock has a market cap of $82.59 billion, a PE ratio of 12.80, a price-to-earnings-growth ratio of 1.18 and a beta of 1.12.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion for the quarter, compared to analysts' expectations of $19.09 billion. During the same period last year, the firm earned $6.45 EPS. The company's revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare's payout ratio is presently 10.73%.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.